Grown Rogue International (GRUSF) Net Margin Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Net Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -3,380.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,380.00 |
| Sep 30, 2025 | 6,173.00 |
| Jan 31, 2023 | 3,190.00 |
| Jan 31, 2022 | 9,109.00 |
| Jul 31, 2021 | 8,650.00 |
| Apr 30, 2021 | 3,547.00 |
| Jan 31, 2021 | 4,301.00 |
| Oct 31, 2020 | 48,612.00 |
| Jul 31, 2020 | 1,064.00 |
| Apr 30, 2020 | -2,251.00 |
| Jan 31, 2020 | 42,972.00 |
| Oct 31, 2019 | -16,574.00 |
| Jul 31, 2019 | 11,585.00 |
| Apr 30, 2019 | 11,427.00 |
| Jan 31, 2019 | -19,321.00 |
| Aug 31, 2015 | 3.02 Mn |
| Feb 28, 2015 | 104,064.00 |
| Aug 31, 2014 | 1,612.00 |
| May 31, 2014 | -574,124.00 |
| Feb 28, 2014 | -84,425.00 |